"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","data_processing.1","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","age:ch1","cell type:ch1","disease status:ch1","sample type:ch1"
"GSM2983085","normal_BMSC_1_cell","GSM2983085","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","Elderly donors (age of donor: 68 years)","Homo sapiens","disease status: Healthy","age: 68 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: control","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","LONZA_BMSC_old_1","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","Bone marrow stromal cells (BMSCs)","Healthy","control"
"GSM2983086","normal_BMSC_2_cell","GSM2983086","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","Elderly donors (age of donor: 72 years)","Homo sapiens","disease status: Healthy","age: 72 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: control","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","LONZA_BMSC_old_2","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","Bone marrow stromal cells (BMSCs)","Healthy","control"
"GSM2983087","MGUS_BMSC_1_cell","GSM2983087","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MGUS patient (age of donor: 53 years)","Homo sapiens","disease status: Monoclonal gammopathy of undetermined significance (MGUS)","age: 53 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MGUS1_BMSC_CM90","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","53 years","Bone marrow stromal cells (BMSCs)","Monoclonal gammopathy of undetermined significance (MGUS)","test"
"GSM2983088","MGUS_BMSC_2_cell","GSM2983088","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MGUS patient (age of donor: 78 years)","Homo sapiens","disease status: Monoclonal gammopathy of undetermined significance (MGUS)","age: 78 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MGUS2_BMSC_CM106","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","78 years","Bone marrow stromal cells (BMSCs)","Monoclonal gammopathy of undetermined significance (MGUS)","test"
"GSM2983089","MGUS_BMSC_13_cell","GSM2983089","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MGUS patient (age of donor: 72 years)","Homo sapiens","disease status: Monoclonal gammopathy of undetermined significance (MGUS)","age: 72 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MGUS13_BMSC_CM45","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","Bone marrow stromal cells (BMSCs)","Monoclonal gammopathy of undetermined significance (MGUS)","test"
"GSM2983090","MM_BMSC_2_cell","GSM2983090","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 82 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 82 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM2_BMSC_CM8","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","82 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
"GSM2983091","MM_BMSC_4_cell","GSM2983091","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 68 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 68 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM4_BMSC_CM22","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
"GSM2983092","MM_BMSC_5_cell","GSM2983092","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 81 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 81 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM5_BMSC_CM33","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","81 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
"GSM2983093","MM_BMSC_12_cell","GSM2983093","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 74 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 74 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM12_BMSC_CM12","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","74 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
"GSM2983094","MM_BMSC_14_cell","GSM2983094","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 68 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 68 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM14_BMSC_CM23","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
"GSM2983095","MM_BMSC_20_cell","GSM2983095","Public on Jun 08 2018","Feb 06 2018","Jun 08 2018","RNA","1","MM patient (age of donor: 74 years)","Homo sapiens","disease status: Multiple myeloma (MM)","age: 74 years","cell type: Bone marrow stromal cells (BMSCs)","sample type: test","n/a","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA).","9606","n/a","n/a","MM20_BMSC_CM40","RNU6B were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","74 years","Bone marrow stromal cells (BMSCs)","Multiple myeloma (MM)","test"
